Is a complete SION research report available?

No complete published report is available for Sionna Therapeutics, Inc. (SION) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Sionna Therapeutics, Inc. (SION)

NASDAQ: SION · USD

$44.8

-1.74 (-3.7%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-30 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first SION analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	2B
Net income (ttm)	-85.6M
EPS (ttm)	-$1.92
Shares out	45.2M
Volume	369,411
Price target	$51.6	+15.2%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -85.6M
EPS (ttm): -$1.92
Market cap: 2B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	38.3B	72.6x	8.9x	78.4%	+49.7%	-11.8%	Strong Buy
ARGX	argenx SE	55.2B	32.2x	10.4x	50.6%	+58.8%	+48.3%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All SION indicators

Market & fundamental data

Available fields

177

Groups with data

Currency

USD

Showing 177 of 177 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0002036042
Company name	Sionna Therapeutics, Inc.
Country	United States
Country code	US
Cusip	829401108
Employees	59
Employees Change	18%
Employees Change Percent	43.9
Enterprise value	$1.7B
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2025-02-07
Isin	US8294011080
Last refreshed	2026-07-30
Market cap	$2B
Market cap category	Mid-Cap
Price	$44.81
Price currency	USD
Sector	Healthcare
Sector PE	45.64
Sector PE Fwd	24.21
Sic	2834
Symbol	SION
Website	https://www.sionnatx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-4.23%
FCF yield	-3.57%
P/B ratio	7.01x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-85.6M
Net Income Growth Years	0%
Profit Per Employee	$-1.5M
ROA	-18.33
ROCE	-33.5
ROE	-26.74
ROIC	-18.8

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	125.87%
EPS Growth Quarters	6
EPS Growth Years	2
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$305M
Cash	$216.2M
Current Assets	$221M
Current Liabilities	$9.8M
Debt	$8.4M
Debt Equity	$0.03
Equity	$288.2M
Liabilities	$16.8M
Long Term Assets	$84.1M
Long Term Liabilities	$7.1M
Net Cash	$281.6M
Net Cash By Market Cap	$13.92
Net Cash Growth	-18.44%
Net Debt Equity	$-0.98
Tangible Book Value	$288.2M
Tangible Book Value Per Share	$6.39

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	22.6
Net Working Capital	$-3.6M
Quick ratio	22.11
Working Capital	$211.2M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-357.46%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	125.74%
200-day SMA	39.65
50-day SMA	41.32
50-day SMA vs 200-day SMA	50over200
All Time High	51.57
All Time High Change	-13.1%
All Time High Date	2026-07-20
All Time Low	7.26
All Time Low Change	517.64%
All Time Low Date	2025-04-11
ATR	3.28
Beta1y	1.37
Beta2y	1.15
Ch YTD	8.92
High	46.84
High52	51.57
High52 Date	2026-07-20
High52ch	-13.1%
Low	44.63
Low52	16.38
Low52 Date	2025-08-01
Low52ch	173.57%
Ma50ch	8.44%
Premarket Change Percent	1.07
Premarket Price	$47.05
Premarket Volume	429
Price vs 200-day SMA	13.01%
RSI	52.3
RSI Monthly	75.37
RSI Weekly	56.23
Sharpe ratio	1.38x
Sortino ratio	2.27
Total Return	-357.46%
Tr YTD	8.92
Tr1m	6.24%
Tr1w	-0.49%
Tr3m	13.19%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	11
Analyst Count Top	9
Analyst Price Target Top	$52.71
Analyst Ratings	Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.64
Operating Income	$-98.9M
Price target	$51.6
Price Target Change	$15.15
Price Target Change Top	$17.63

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	16,760,878%
Float Percent	37.12%
Shares Insiders	1.43%
Shares Institutions	43.14%
Shares Out	45,150,330
Shares Qo Q	0.64%
Shares Yo Y	357.46%
Short Float	31.37%
Short Ratio	10.62
Short Shares	11.64

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-88.7M
Adjusted OCF	-88,374,000
Average Volume	568,636.1x
Bv Per Share	6.39
CAPEX	$-291,000
Ch1m	6.24
Ch1w	-0.49
Ch1y	125.7
Ch3m	13.19
Ch6m	6.36
Change	-3.74%
Change From Open	-4.27
Close	46.55
Days Gap	0.56
Depreciation Amortization	642,000
Dollar Volume	16,553,306.9
Earnings Date	2026-08-11
Earnings Time	bmo
EBIT	$-98.9M
EBITDA	$-98.3M
EPS	$-1.92
F Score	1
FCF	$-72.1M
FCF EV Yield	-4.14x
FCF Per Share	$-1.6
Financing CF	5,214,000
Fiscal Year End	December
Founded	2,019
Investing CF	47,265,000
Ipr	148.9
Iprfo	79.24
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-12
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-03-02
Ma150	40.03
Ma150ch	11.94%
Ma20	44.9
Ma20ch	-0.2%
Net CF	-19,370,000
Next Earnings Date	2026-08-10
Open	46.81
Optionable	Yes
Position In Range	8.14
Post Close	44.81
Postmarket Change Percent	-0.67
Postmarket Price	$44.51
Ppne	8,751,000
Pre Close	46.55
Price Date	2026-07-29
Ptbv Ratio	7.02
Relative Volume	0.65x
Share Based Comp	16,525,000
Tr6m	6.36%
Us State	Massachusetts
Volume	369,411

Sionna Therapeutics, Inc. (SION)

Coverage state: Market snapshot only — no published research

Generate the first SION analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · SION

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All SION indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on SION

Frequently asked questions